semaglutide chronic kidney disease

Ozempic receives FDA nod for treating chronic kidney disease

FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic kidney disease,

Medscape · 1d

Ozempic Receives New Indications in Chronic Kidney Disease

Semaglutide is now approved for reducing the risk for worsening kidney disease and cardiovascular death in adults with chronic kidney disease.

infectiousdiseaseadvisor.com · 2h

Ozempic Approval Expanded to Include T2D Patients With Chronic Kidney Disease

The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.

The American Journal of Managed Care2d

FDA Expands Semaglutide Use for CV, Kidney Risks in T2D, CKD

The latest semaglutide (Ozempic; Novo Nordisk) approval is set to tackle a major need for patients with both type 2 diabetes ...

Rolling Out11d

How semaglutide is transforming kidney disease treatment

Semaglutide is revolutionizing kidney disease treatment for type 2 diabetes patients. Learn how it works and its potential ...

MedPage Today3d

Ozempic Approved for Diabetic Kidney Disease

It does not apply to 1.7 mg or 2.4 mg semaglutide (Wegovy), which is indicated for chronic weight management. Chronic kidney disease is a common complication of type 2 diabetes; around 40% ...

The American Journal of Managed Care1d

Case Series Shows Possible Link Between Semaglutide, Ophthalmic Complications

Results from a case series identified a potential association between ophthalmic complications and the rapid correction of hyperglycemia, brought on by patients using either semaglutide or tirzepatide ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results